| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.39e-05 | 2 | 75 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.39e-05 | 2 | 75 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.17e-05 | 3 | 75 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.54e-05 | 20 | 75 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 6.45e-05 | 21 | 75 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.11e-04 | 66 | 75 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.11e-04 | 66 | 75 | 4 | GO:0001098 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 2.07e-04 | 6 | 75 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | SMAD binding | 3.09e-04 | 86 | 75 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.32e-04 | 36 | 75 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | cAMP response element binding | 8.97e-04 | 12 | 75 | 2 | GO:0035497 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 9.31e-04 | 51 | 75 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 9.72e-04 | 303 | 75 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.16e-03 | 55 | 75 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.18e-03 | 560 | 75 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.26e-03 | 566 | 75 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.42e-03 | 15 | 75 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.49e-03 | 60 | 75 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.57e-03 | 61 | 75 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.61e-03 | 16 | 75 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | snRNP binding | 1.61e-03 | 16 | 75 | 2 | GO:0070990 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.76e-03 | 739 | 75 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 1.80e-03 | 64 | 75 | 3 | GO:0140296 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.91e-03 | 140 | 75 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.00e-03 | 753 | 75 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | p53 binding | 3.05e-03 | 77 | 75 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.16e-03 | 78 | 75 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 3.35e-03 | 23 | 75 | 2 | GO:0071837 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.60e-03 | 27 | 75 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 4.60e-03 | 27 | 75 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.79e-03 | 417 | 75 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 5.13e-03 | 562 | 75 | 7 | GO:0003712 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 2.55e-05 | 162 | 74 | 6 | GO:0018205 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 7.46e-05 | 23 | 74 | 3 | GO:0090161 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 7.58e-05 | 4 | 74 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA3 KMT2C JUN YBX1 ZMIZ2 NFYA POU3F2 E2F4 E4F1 ZMIZ1 CREBBP EP300 MEIS2 CDON TBP | 1.04e-04 | 1390 | 74 | 15 | GO:0045944 |
| GeneOntologyCellularComponent | chromatin | PIAS4 NCOA3 JUN EP400 ZNF618 ZMIZ2 NFYA POU3F2 E2F4 ZMIZ1 CREBBP EP300 MEIS2 TBP HELLS | 1.80e-04 | 1480 | 74 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | histone pre-mRNA 3'end processing complex | 1.84e-04 | 6 | 74 | 2 | GO:0071204 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 4.06e-04 | 272 | 74 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | U4/U6 x U5 tri-snRNP complex | 6.17e-04 | 47 | 74 | 3 | GO:0046540 | |
| GeneOntologyCellularComponent | spliceosomal tri-snRNP complex | 6.57e-04 | 48 | 74 | 3 | GO:0097526 | |
| GeneOntologyCellularComponent | U4 snRNP | 9.40e-04 | 13 | 74 | 2 | GO:0005687 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | PCF11 NCOA3 KMT2C JUN EP400 YBX1 NFYA E2F4 SNRPB LSM5 CREBBP SNRPN TBP | 1.00e-03 | 1377 | 74 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | 1.20e-03 | 596 | 74 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 1.82e-03 | 18 | 74 | 2 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 1.82e-03 | 18 | 74 | 2 | GO:0071010 | |
| HumanPheno | Precocious puberty | 1.73e-06 | 186 | 25 | 8 | HP:0000826 | |
| HumanPheno | Early onset of sexual maturation | 1.95e-06 | 189 | 25 | 8 | HP:0100000 | |
| HumanPheno | Sporadic | 7.66e-06 | 103 | 25 | 6 | HP:0003745 | |
| HumanPheno | Plantar crease between first and second toes | 2.31e-05 | 2 | 25 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.31e-05 | 2 | 25 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.31e-05 | 2 | 25 | 2 | HP:0001042 | |
| HumanPheno | Nasogastric tube feeding in infancy | 2.67e-05 | 37 | 25 | 4 | HP:0011470 | |
| HumanPheno | Broad toe | 5.25e-05 | 87 | 25 | 5 | HP:0001837 | |
| HumanPheno | Laryngeal cartilage malformation | 6.92e-05 | 3 | 25 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 6.92e-05 | 3 | 25 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 6.92e-05 | 3 | 25 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 6.92e-05 | 3 | 25 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 6.92e-05 | 3 | 25 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 6.92e-05 | 3 | 25 | 2 | HP:0005895 | |
| HumanPheno | Short finger | 1.04e-04 | 325 | 25 | 8 | HP:0009381 | |
| HumanPheno | Narrow nasal bridge | 1.12e-04 | 53 | 25 | 4 | HP:0000446 | |
| HumanPheno | Trichiasis | 1.38e-04 | 4 | 25 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.38e-04 | 4 | 25 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.38e-04 | 4 | 25 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.38e-04 | 4 | 25 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.38e-04 | 4 | 25 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.38e-04 | 4 | 25 | 2 | HP:0031207 | |
| HumanPheno | Abnormal esophagus physiology | KMT2C POLG ZMYM2 SNRPB GRM7 METTL27 CREBBP EP300 LETM1 MEIS2 MYORG CDON TBP | 1.41e-04 | 933 | 25 | 13 | HP:0025270 |
| HumanPheno | Carious teeth | 1.50e-04 | 174 | 25 | 6 | HP:0000670 | |
| HumanPheno | Cerebral visual impairment | 1.76e-04 | 179 | 25 | 6 | HP:0100704 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | COL10A1 ZMYM2 ZMIZ1 SNRPB GRM7 CREBBP SNRPN EP300 LETM1 MEIS2 | 2.00e-04 | 572 | 25 | 10 | HP:0006496 |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.29e-04 | 5 | 25 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.29e-04 | 5 | 25 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.29e-04 | 5 | 25 | 2 | HP:0030421 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | 2.40e-04 | 366 | 25 | 8 | HP:0006265 | |
| HumanPheno | Phonophobia | 2.52e-04 | 26 | 25 | 3 | HP:0002183 | |
| HumanPheno | Perimembranous ventricular septal defect | 2.52e-04 | 26 | 25 | 3 | HP:0011682 | |
| HumanPheno | Abnormal upper limb bone morphology | 2.98e-04 | 484 | 25 | 9 | HP:0040070 | |
| HumanPheno | Abnormal lateral ventricle morphology | 3.41e-04 | 129 | 25 | 5 | HP:0030047 | |
| HumanPheno | Large foramen magnum | 3.43e-04 | 6 | 25 | 2 | HP:0002700 | |
| HumanPheno | Short columella | 3.51e-04 | 29 | 25 | 3 | HP:0002000 | |
| HumanPheno | Microcephaly | KMT2C POLG ZMYM2 THUMPD1 COG5 SNRPB GRM7 METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 MYORG CDON | 3.83e-04 | 1341 | 25 | 15 | HP:0000252 |
| HumanPheno | Preaxial foot polydactyly | 3.89e-04 | 30 | 25 | 3 | HP:0001841 | |
| HumanPheno | Diagnostic behavioral phenotype | KMT2C POLG ZMYM2 ZMIZ1 COG5 GRM7 METTL27 CREBBP SNRPN EP300 MEIS2 | 3.90e-04 | 747 | 25 | 11 | HP:0025783 |
| HumanPheno | Decreased head circumference | KMT2C POLG ZMYM2 THUMPD1 COG5 SNRPB GRM7 METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 MYORG CDON | 4.29e-04 | 1354 | 25 | 15 | HP:0040195 |
| HumanPheno | Abnormal hallux morphology | 4.41e-04 | 212 | 25 | 6 | HP:0001844 | |
| HumanPheno | Broad hallux | 4.56e-04 | 76 | 25 | 4 | HP:0010055 | |
| HumanPheno | Tethered cord | 4.72e-04 | 32 | 25 | 3 | HP:0002144 | |
| HumanPheno | Tube feeding | 4.75e-04 | 215 | 25 | 6 | HP:0033454 | |
| HumanPheno | Deviated nasal septum | 4.78e-04 | 7 | 25 | 2 | HP:0004411 | |
| HumanPheno | Gastroesophageal reflux | 4.91e-04 | 517 | 25 | 9 | HP:0002020 | |
| HumanPheno | Abnormal conus terminalis morphology | 5.17e-04 | 33 | 25 | 3 | HP:0031938 | |
| HumanPheno | Obstructive sleep apnea | 5.29e-04 | 79 | 25 | 4 | HP:0002870 | |
| HumanPheno | Vesicoureteral reflux | 5.51e-04 | 221 | 25 | 6 | HP:0000076 | |
| HumanPheno | Aspiration | 5.65e-04 | 34 | 25 | 3 | HP:0002835 | |
| HumanPheno | Abnormal esophagus morphology | KMT2C POLG ZMYM2 SNRPB GRM7 METTL27 CREBBP EP300 LETM1 MEIS2 MYORG CDON TBP | 6.36e-04 | 1078 | 25 | 13 | HP:0002031 |
| HumanPheno | Broad phalanx | 6.42e-04 | 148 | 25 | 5 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 6.42e-04 | 148 | 25 | 5 | HP:0009768 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 6.60e-04 | 538 | 25 | 9 | HP:0005927 | |
| HumanPheno | Hydrocele testis | 6.70e-04 | 36 | 25 | 3 | HP:0000034 | |
| HumanPheno | Short stature | KMT2C COL10A1 ZMYM2 THUMPD1 COG5 SNRPB GRM7 METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 CDON HELLS | 6.74e-04 | 1407 | 25 | 15 | HP:0004322 |
| HumanPheno | Brachydactyly (hand) | 7.21e-04 | 430 | 25 | 8 | HP:0100667 | |
| HumanPheno | Auditory sensitivity | 7.27e-04 | 37 | 25 | 3 | HP:0025112 | |
| HumanPheno | Accessory spleen | 7.27e-04 | 37 | 25 | 3 | HP:0001747 | |
| HumanPheno | Auditory hypersensitivity | 7.27e-04 | 37 | 25 | 3 | HP:5200060 | |
| HumanPheno | Broad finger | 7.70e-04 | 154 | 25 | 5 | HP:0001500 | |
| HumanPheno | Abnormal forearm bone morphology | 7.81e-04 | 236 | 25 | 6 | HP:0040072 | |
| HumanPheno | Natal tooth | 7.87e-04 | 38 | 25 | 3 | HP:0000695 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | 7.91e-04 | 436 | 25 | 8 | HP:0040065 | |
| HumanPheno | Deviation of the hallux | 7.97e-04 | 88 | 25 | 4 | HP:0010051 | |
| HumanPheno | Autistic behavior | KMT2C ZMYM2 ZMIZ1 COG5 GRM7 METTL27 CREBBP SNRPN EP300 MEIS2 | 8.11e-04 | 678 | 25 | 10 | HP:0000729 |
| HumanPheno | Pilomatrixoma | 8.15e-04 | 9 | 25 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 8.15e-04 | 9 | 25 | 2 | HP:0002341 | |
| HumanPheno | Abnormal forearm morphology | 8.35e-04 | 239 | 25 | 6 | HP:0002973 | |
| HumanPheno | Broad long bones | 8.41e-04 | 157 | 25 | 5 | HP:0005622 | |
| HumanPheno | Cellular immunodeficiency | 8.49e-04 | 39 | 25 | 3 | HP:0005374 | |
| HumanPheno | Abnormal long bone morphology | COL10A1 ZMIZ1 COG5 SNRPB GRM7 METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 | 8.96e-04 | 821 | 25 | 11 | HP:0011314 |
| HumanPheno | Abnormal ureter physiology | 9.52e-04 | 245 | 25 | 6 | HP:0025634 | |
| HumanPheno | Scoliosis | KMT2C COL10A1 POLG ZMYM2 ZMIZ1 SNRPB METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 CDON | 9.54e-04 | 1122 | 25 | 13 | HP:0002650 |
| HumanPheno | Hip dysplasia | 9.93e-04 | 247 | 25 | 6 | HP:0001385 | |
| HumanPheno | Frontal hirsutism | 1.02e-03 | 10 | 25 | 2 | HP:0011335 | |
| HumanPheno | Abnormal ulnar metaphysis morphology | 1.02e-03 | 10 | 25 | 2 | HP:0004039 | |
| HumanPheno | Convex nasal ridge | 1.06e-03 | 95 | 25 | 4 | HP:0000444 | |
| HumanPheno | Brain imaging abnormality | 1.11e-03 | 167 | 25 | 5 | HP:0410263 | |
| HumanPheno | Abnormal columella morphology | 1.15e-03 | 97 | 25 | 4 | HP:0009929 | |
| HumanPheno | Abnormal subclavian artery morphology | 1.24e-03 | 11 | 25 | 2 | HP:0031251 | |
| HumanPheno | Abnormal spinal cord morphology | 1.25e-03 | 357 | 25 | 7 | HP:0002143 | |
| HumanPheno | Functional abnormality of the bladder | 1.30e-03 | 590 | 25 | 9 | HP:0000009 | |
| HumanPheno | Supernumerary spleens | 1.34e-03 | 101 | 25 | 4 | HP:0009799 | |
| HumanPheno | Constipation | 1.34e-03 | 472 | 25 | 8 | HP:0002019 | |
| HumanPheno | Advanced eruption of teeth | 1.38e-03 | 46 | 25 | 3 | HP:0006288 | |
| HumanPheno | Sleep abnormality | 1.40e-03 | 596 | 25 | 9 | HP:0002360 | |
| HumanPheno | Abnormally increased volition | KMT2C POLG ZMYM2 ZMIZ1 GRM7 METTL27 CREBBP SNRPN EP300 CDON TBP | 1.46e-03 | 869 | 25 | 11 | HP:5200263 |
| HumanPheno | Broad phalanx of the toes | 1.47e-03 | 47 | 25 | 3 | HP:0010174 | |
| HumanPheno | Abnormality of dental structure | 1.49e-03 | 368 | 25 | 7 | HP:0011061 | |
| HumanPheno | Abnormality of the palpebral fissures | KMT2C ZMYM2 THUMPD1 ZMIZ1 SNRPB METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 | 1.63e-03 | 880 | 25 | 11 | HP:0008050 |
| HumanPheno | Abnormal nasal bridge morphology | ZMYM2 ZMIZ1 COG5 GRM7 METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 CDON HELLS | 1.64e-03 | 1029 | 25 | 12 | HP:0000422 |
| HumanPheno | Tracheomalacia | 1.66e-03 | 49 | 25 | 3 | HP:0002779 | |
| HumanPheno | Abnormal stomach morphology | KMT2C POLG SNRPB METTL27 CREBBP SNRPN EP300 LETM1 MEIS2 CDON | 1.66e-03 | 742 | 25 | 10 | HP:0002577 |
| HumanPheno | Epicanthus | 1.73e-03 | 614 | 25 | 9 | HP:0000286 | |
| HumanPheno | Facial grimacing | 1.75e-03 | 13 | 25 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 1.75e-03 | 13 | 25 | 2 | HP:0010562 | |
| HumanPheno | Smooth philtrum | 1.76e-03 | 185 | 25 | 5 | HP:0000319 | |
| HumanPheno | Prominent nose | 1.84e-03 | 110 | 25 | 4 | HP:0000448 | |
| HumanPheno | Patent ductus arteriosus | 1.85e-03 | 382 | 25 | 7 | HP:0001643 | |
| Domain | Nuc_rcpt_coact | 1.28e-06 | 6 | 76 | 3 | IPR009110 | |
| Domain | zf-MIZ | 2.24e-06 | 7 | 76 | 3 | PF02891 | |
| Domain | ZF_SP_RING | 2.24e-06 | 7 | 76 | 3 | PS51044 | |
| Domain | Znf_MIZ | 3.57e-06 | 8 | 76 | 3 | IPR004181 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.63e-05 | 2 | 76 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.63e-05 | 2 | 76 | 2 | PF08214 | |
| Domain | KIX | 1.63e-05 | 2 | 76 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.63e-05 | 2 | 76 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.63e-05 | 2 | 76 | 2 | IPR031162 | |
| Domain | DUF902 | 1.63e-05 | 2 | 76 | 2 | PF06001 | |
| Domain | - | 1.63e-05 | 2 | 76 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.63e-05 | 2 | 76 | 2 | IPR010303 | |
| Domain | - | 1.63e-05 | 2 | 76 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.63e-05 | 2 | 76 | 2 | PF09030 | |
| Domain | snRNP-assoc_SmB/SmN | 1.63e-05 | 2 | 76 | 2 | IPR017131 | |
| Domain | - | 1.63e-05 | 2 | 76 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.63e-05 | 2 | 76 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.63e-05 | 2 | 76 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.63e-05 | 2 | 76 | 2 | IPR013178 | |
| Domain | KAT11 | 1.63e-05 | 2 | 76 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.63e-05 | 2 | 76 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.63e-05 | 2 | 76 | 2 | IPR003101 | |
| Domain | KIX | 1.63e-05 | 2 | 76 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.63e-05 | 2 | 76 | 2 | PS51727 | |
| Domain | Sm | 5.99e-05 | 19 | 76 | 3 | SM00651 | |
| Domain | LSM | 5.99e-05 | 19 | 76 | 3 | PF01423 | |
| Domain | LSM_dom_euk/arc | 5.99e-05 | 19 | 76 | 3 | IPR001163 | |
| Domain | LSM_dom | 9.43e-05 | 22 | 76 | 3 | IPR010920 | |
| Domain | NUT | 1.62e-04 | 5 | 76 | 2 | IPR024310 | |
| Domain | NUT_N | 1.62e-04 | 5 | 76 | 2 | IPR024309 | |
| Domain | NUT | 1.62e-04 | 5 | 76 | 2 | PF12881 | |
| Domain | FH2 | 1.66e-03 | 15 | 76 | 2 | PS51444 | |
| Domain | FH2_Formin | 1.66e-03 | 15 | 76 | 2 | IPR015425 | |
| Domain | FH2 | 1.66e-03 | 15 | 76 | 2 | PF02181 | |
| Domain | FH2 | 1.66e-03 | 15 | 76 | 2 | SM00498 | |
| Domain | ZZ | 2.40e-03 | 18 | 76 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.40e-03 | 18 | 76 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.40e-03 | 18 | 76 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.67e-03 | 19 | 76 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.67e-03 | 19 | 76 | 2 | SM00291 | |
| Domain | TSPN | 3.91e-03 | 23 | 76 | 2 | SM00210 | |
| Domain | Bromodomain_CS | 4.99e-03 | 26 | 76 | 2 | IPR018359 | |
| Domain | SNF2_N | 7.49e-03 | 32 | 76 | 2 | IPR000330 | |
| Domain | SNF2_N | 7.49e-03 | 32 | 76 | 2 | PF00176 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 1.89e-06 | 91 | 58 | 6 | M39700 | |
| Pathway | PID_RB_1PATHWAY | 6.76e-06 | 65 | 58 | 5 | M279 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.12e-05 | 82 | 58 | 5 | M2 | |
| Pathway | PID_HNF3A_PATHWAY | 3.10e-05 | 44 | 58 | 4 | M285 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 3.56e-05 | 16 | 58 | 3 | M27940 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 4.67e-05 | 159 | 58 | 6 | M39373 | |
| Pathway | PID_AR_TF_PATHWAY | 6.50e-05 | 53 | 58 | 4 | M151 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 9.63e-05 | 22 | 58 | 3 | MM1370 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 1.42e-04 | 122 | 58 | 5 | M29689 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.61e-04 | 26 | 58 | 3 | M2499 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.65e-04 | 5 | 58 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.65e-04 | 5 | 58 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.65e-04 | 5 | 58 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.65e-04 | 5 | 58 | 2 | M27228 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.47e-04 | 6 | 58 | 2 | M22062 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 2.47e-04 | 6 | 58 | 2 | MM1447 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.48e-04 | 30 | 58 | 3 | M207 | |
| Pathway | WP_ESTROGEN_SIGNALING | 2.79e-04 | 77 | 58 | 4 | MM15934 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.45e-04 | 7 | 58 | 2 | MM1573 | |
| Pathway | PID_REG_GR_PATHWAY | 3.55e-04 | 82 | 58 | 4 | M115 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.60e-04 | 149 | 58 | 5 | M27888 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 4.26e-04 | 86 | 58 | 4 | M2642 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 4.29e-04 | 36 | 58 | 3 | M633 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.58e-04 | 8 | 58 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.58e-04 | 8 | 58 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.58e-04 | 8 | 58 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.58e-04 | 8 | 58 | 2 | M46443 | |
| Pathway | PID_IFNG_PATHWAY | 5.86e-04 | 40 | 58 | 3 | M161 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 5.88e-04 | 9 | 58 | 2 | MM1533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.88e-04 | 9 | 58 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 7.33e-04 | 10 | 58 | 2 | M27945 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 7.77e-04 | 44 | 58 | 3 | M27295 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 7.83e-04 | 101 | 58 | 4 | M39387 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 7.83e-04 | 101 | 58 | 4 | MM15829 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.93e-04 | 11 | 58 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.93e-04 | 11 | 58 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 8.93e-04 | 11 | 58 | 2 | M26924 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.06e-03 | 49 | 58 | 3 | M618 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.07e-03 | 12 | 58 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.07e-03 | 12 | 58 | 2 | M27765 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 1.08e-03 | 110 | 58 | 4 | MM15977 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.20e-03 | 51 | 58 | 3 | M665 | |
| Pathway | BIOCARTA_PCAF_PATHWAY | 1.26e-03 | 13 | 58 | 2 | M22007 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.27e-03 | 52 | 58 | 3 | M2404 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.34e-03 | 53 | 58 | 3 | MM15880 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.40e-03 | 118 | 58 | 4 | M27316 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.44e-03 | 301 | 58 | 6 | MM15983 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.47e-03 | 14 | 58 | 2 | M27808 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.49e-03 | 55 | 58 | 3 | M39351 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.69e-03 | 15 | 58 | 2 | MM1339 | |
| Pathway | BIOCARTA_HIF_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M13324 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.69e-03 | 15 | 58 | 2 | MM1439 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 1.69e-03 | 15 | 58 | 2 | M48323 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M953 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.82e-03 | 59 | 58 | 3 | M261 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.82e-03 | 59 | 58 | 3 | M39886 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 1.82e-03 | 59 | 58 | 3 | MM15838 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.92e-03 | 16 | 58 | 2 | M27121 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.92e-03 | 16 | 58 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.92e-03 | 16 | 58 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.92e-03 | 16 | 58 | 2 | M8516 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.07e-03 | 220 | 58 | 5 | M27794 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 2.17e-03 | 17 | 58 | 2 | M14449 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.17e-03 | 17 | 58 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.17e-03 | 17 | 58 | 2 | M48025 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 2.17e-03 | 17 | 58 | 2 | MM1435 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 2.20e-03 | 63 | 58 | 3 | M254 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 2.30e-03 | 64 | 58 | 3 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.41e-03 | 65 | 58 | 3 | M39682 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 2.41e-03 | 137 | 58 | 4 | M145 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 2.44e-03 | 18 | 58 | 2 | M673 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.44e-03 | 18 | 58 | 2 | M26942 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST | 2.44e-03 | 18 | 58 | 2 | M27633 | |
| Pathway | PID_HIF1_TFPATHWAY | 2.52e-03 | 66 | 58 | 3 | M255 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 2.52e-03 | 66 | 58 | 3 | M27938 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.72e-03 | 19 | 58 | 2 | M18933 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.72e-03 | 19 | 58 | 2 | M41732 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.72e-03 | 19 | 58 | 2 | M46442 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 2.98e-03 | 70 | 58 | 3 | M13266 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.98e-03 | 70 | 58 | 3 | M3115 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.01e-03 | 20 | 58 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 3.32e-03 | 21 | 58 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.32e-03 | 21 | 58 | 2 | M27485 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 3.35e-03 | 73 | 58 | 3 | M39401 | |
| Pathway | PID_E2F_PATHWAY | 3.35e-03 | 73 | 58 | 3 | M40 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.65e-03 | 22 | 58 | 2 | MM1443 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.98e-03 | 23 | 58 | 2 | M2821 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 4.31e-03 | 161 | 58 | 4 | M27871 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.33e-03 | 24 | 58 | 2 | M13404 | |
| Pubmed | PCF11 NCOA3 KMT2C JUN NOL4L EP400 ADRM1 YBX1 ZMIZ2 DGKK NFYA MYO18A ZMYM2 R3HDM2 ZMIZ1 CREBBP EP300 TBP HELLS | 2.13e-10 | 1429 | 77 | 19 | 35140242 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 9590171 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 1.04e-08 | 3 | 77 | 3 | 11823864 | |
| Pubmed | 2.98e-08 | 15 | 77 | 4 | 9267036 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 8995708 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 16227615 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 33589584 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 28398509 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 4.17e-08 | 4 | 77 | 3 | 10655477 | |
| Pubmed | Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB. | 4.17e-08 | 4 | 77 | 3 | 12437352 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 9194565 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 11701890 | ||
| Pubmed | 4.93e-08 | 152 | 77 | 7 | 38360978 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 8.65e-08 | 351 | 77 | 9 | 38297188 | |
| Pubmed | Human p300 protein is a coactivator for the transcription factor MyoD. | 1.04e-07 | 5 | 77 | 3 | 8621548 | |
| Pubmed | 1.05e-07 | 20 | 77 | 4 | 11877444 | ||
| Pubmed | PCF11 TPP2 NCOA3 KMT2C JUN NOL4L EP400 YBX1 ZMIZ2 ZMYM2 LSM5 CREBBP EP300 HELLS | 1.25e-07 | 1103 | 77 | 14 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PIAS4 KMT2C JUN ZNF628 EP400 ZMIZ2 POLG ARHGAP44 TXNRD3 RIPOR1 METTL27 D2HGDH EP300 MYORG | 1.28e-07 | 1105 | 77 | 14 | 35748872 |
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 2.08e-07 | 6 | 77 | 3 | 11076796 | |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 20159969 | ||
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 11029584 | ||
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 10327051 | ||
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 10497212 | ||
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 26871568 | ||
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 21565167 | ||
| Pubmed | 3.63e-07 | 7 | 77 | 3 | 16858508 | ||
| Pubmed | Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. | 5.80e-07 | 8 | 77 | 3 | 16055710 | |
| Pubmed | 5.80e-07 | 8 | 77 | 3 | 17475621 | ||
| Pubmed | 5.80e-07 | 8 | 77 | 3 | 10490106 | ||
| Pubmed | The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription. | 8.68e-07 | 9 | 77 | 3 | 14612417 | |
| Pubmed | 1.18e-06 | 83 | 77 | 5 | 28794006 | ||
| Pubmed | 1.24e-06 | 10 | 77 | 3 | 15601870 | ||
| Pubmed | 1.24e-06 | 10 | 77 | 3 | 11163245 | ||
| Pubmed | 1.31e-06 | 486 | 77 | 9 | 20936779 | ||
| Pubmed | 1.70e-06 | 11 | 77 | 3 | 10454579 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 2.00e-06 | 167 | 77 | 6 | 20362541 | |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 2.26e-06 | 12 | 77 | 3 | 14645221 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | JUN EP400 NFYA ZMYM2 THUMPD1 E4F1 COG5 CREBBP EP300 TBP HELLS | 2.90e-06 | 857 | 77 | 11 | 25609649 |
| Pubmed | A functional interaction between the survival motor neuron complex and RNA polymerase II. | 2.94e-06 | 13 | 77 | 3 | 11149922 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 3.61e-06 | 877 | 77 | 11 | 20211142 | |
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 3.73e-06 | 14 | 77 | 3 | 15333839 | |
| Pubmed | 4.66e-06 | 15 | 77 | 3 | 10567404 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.84e-06 | 2 | 77 | 2 | 34845315 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19729597 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15860545 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29460469 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28675294 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 4.84e-06 | 2 | 77 | 2 | 24551300 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21705419 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 33911074 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9018065 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24648406 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 30135524 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 4.84e-06 | 2 | 77 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 4.84e-06 | 2 | 77 | 2 | 29217654 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20717166 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 4.84e-06 | 2 | 77 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 4.84e-06 | 2 | 77 | 2 | 29170789 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25893291 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11559821 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 4.84e-06 | 2 | 77 | 2 | 12646247 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 32576962 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19822209 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24522976 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.84e-06 | 2 | 77 | 2 | 21847097 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 8510173 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 4.84e-06 | 2 | 77 | 2 | 11963968 | |
| Pubmed | Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer. | 4.84e-06 | 2 | 77 | 2 | 27322736 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.84e-06 | 2 | 77 | 2 | 34813504 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 4.84e-06 | 2 | 77 | 2 | 12696060 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20301699 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 4.84e-06 | 2 | 77 | 2 | 36109165 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24639469 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 37816914 | ||
| Pubmed | Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin. | 4.84e-06 | 2 | 77 | 2 | 21632823 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12242694 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18053775 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 4.84e-06 | 2 | 77 | 2 | 11438528 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10918613 | ||
| Pubmed | Abnormal Ca2+ dynamics in transgenic mice with neuron-specific mitochondrial DNA defects. | 4.84e-06 | 2 | 77 | 2 | 17122057 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31182547 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 35502657 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 30635043 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31898871 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 4.84e-06 | 2 | 77 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 4.84e-06 | 2 | 77 | 2 | 30888860 | |
| Pubmed | Posttranslational regulation of NF-YA modulates NF-Y transcriptional activity. | 4.84e-06 | 2 | 77 | 2 | 18815279 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 4.84e-06 | 2 | 77 | 2 | 27881443 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19272189 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 4.84e-06 | 2 | 77 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 4.84e-06 | 2 | 77 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 4.84e-06 | 2 | 77 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 4.84e-06 | 2 | 77 | 2 | 32690000 | |
| Interaction | ETS1 interactions | 5.97e-10 | 121 | 74 | 9 | int:ETS1 | |
| Interaction | SPIB interactions | 8.64e-09 | 20 | 74 | 5 | int:SPIB | |
| Interaction | NFYB interactions | 1.39e-07 | 65 | 74 | 6 | int:NFYB | |
| Interaction | ETV4 interactions | 1.99e-07 | 69 | 74 | 6 | int:ETV4 | |
| Interaction | CRX interactions | 3.77e-07 | 254 | 74 | 9 | int:CRX | |
| Interaction | POU3F2 interactions | 7.76e-07 | 20 | 74 | 4 | int:POU3F2 | |
| Interaction | GTF2B interactions | 8.60e-07 | 141 | 74 | 7 | int:GTF2B | |
| Interaction | CTBP1 interactions | 2.25e-06 | 406 | 74 | 10 | int:CTBP1 | |
| Interaction | NFYA interactions | 2.41e-06 | 105 | 74 | 6 | int:NFYA | |
| Interaction | SPI1 interactions | 4.71e-06 | 67 | 74 | 5 | int:SPI1 | |
| Interaction | KLF5 interactions | 7.42e-06 | 195 | 74 | 7 | int:KLF5 | |
| Interaction | HNF4A interactions | 7.51e-06 | 275 | 74 | 8 | int:HNF4A | |
| Interaction | BANP interactions | 7.92e-06 | 277 | 74 | 8 | int:BANP | |
| Interaction | CEBPA interactions | PCF11 TPP2 NCOA3 KMT2C JUN NOL4L EP400 YBX1 ZMIZ2 NFYA ZMYM2 E2F4 LSM5 CREBBP EP300 HELLS | 9.12e-06 | 1245 | 74 | 16 | int:CEBPA |
| Interaction | HDAC1 interactions | PIAS4 JUN EP400 ADRM1 ZMIZ2 NFYA ZMYM2 E2F4 E4F1 ZMIZ1 CREBBP EP300 TMEM33 TBP HELLS | 9.87e-06 | 1108 | 74 | 15 | int:HDAC1 |
| Interaction | SMAD2 interactions | 1.14e-05 | 385 | 74 | 9 | int:SMAD2 | |
| Interaction | SOX7 interactions | 1.27e-05 | 82 | 74 | 5 | int:SOX7 | |
| Interaction | AR interactions | PCF11 PIAS4 NCOA3 KMT2C JUN EP400 ZMIZ2 MYO18A ZMYM2 E2F4 ZMIZ1 CREBBP EP300 TBP | 1.29e-05 | 992 | 74 | 14 | int:AR |
| Interaction | SP7 interactions | 1.55e-05 | 304 | 74 | 8 | int:SP7 | |
| Interaction | PPP1R13L interactions | 1.80e-05 | 88 | 74 | 5 | int:PPP1R13L | |
| Interaction | TOP3B interactions | PIAS4 KMT2C JUN ZNF628 EP400 YBX1 ZMIZ2 POLG ARHGAP44 TXNRD3 RIPOR1 R3HDM2 SNRPB METTL27 D2HGDH EP300 MYORG | 1.81e-05 | 1470 | 74 | 17 | int:TOP3B |
| Interaction | FOS interactions | 1.87e-05 | 312 | 74 | 8 | int:FOS | |
| Interaction | SMAD4 interactions | 2.31e-05 | 530 | 74 | 10 | int:SMAD4 | |
| Interaction | PIAS3 interactions | 2.61e-05 | 95 | 74 | 5 | int:PIAS3 | |
| Interaction | SOX9 interactions | 2.88e-05 | 97 | 74 | 5 | int:SOX9 | |
| Interaction | EYA4 interactions | 3.08e-05 | 243 | 74 | 7 | int:EYA4 | |
| Interaction | FMNL3 interactions | 3.13e-05 | 49 | 74 | 4 | int:FMNL3 | |
| Interaction | SMAD3 interactions | 3.70e-05 | 447 | 74 | 9 | int:SMAD3 | |
| Interaction | EGR2 interactions | 3.93e-05 | 171 | 74 | 6 | int:EGR2 | |
| Interaction | TBP interactions | 3.98e-05 | 253 | 74 | 7 | int:TBP | |
| Interaction | PIAS1 interactions | 4.51e-05 | 353 | 74 | 8 | int:PIAS1 | |
| Interaction | ELF3 interactions | 4.61e-05 | 54 | 74 | 4 | int:ELF3 | |
| Interaction | CIITA interactions | 4.96e-05 | 55 | 74 | 4 | int:CIITA | |
| Interaction | BCL3 interactions | 5.32e-05 | 56 | 74 | 4 | int:BCL3 | |
| Interaction | JUN interactions | 5.45e-05 | 470 | 74 | 9 | int:JUN | |
| Interaction | PAX6 interactions | 5.82e-05 | 366 | 74 | 8 | int:PAX6 | |
| Interaction | ZBTB7B interactions | 5.82e-05 | 366 | 74 | 8 | int:ZBTB7B | |
| Interaction | ETS2 interactions | 7.46e-05 | 61 | 74 | 4 | int:ETS2 | |
| Interaction | MYOD1 interactions | 7.92e-05 | 194 | 74 | 6 | int:MYOD1 | |
| Interaction | CEBPD interactions | 7.95e-05 | 62 | 74 | 4 | int:CEBPD | |
| Interaction | CITED2 interactions | 7.98e-05 | 23 | 74 | 3 | int:CITED2 | |
| Interaction | SUMO1 interactions | 8.80e-05 | 287 | 74 | 7 | int:SUMO1 | |
| Interaction | HCFC1 interactions | 1.00e-04 | 293 | 74 | 7 | int:HCFC1 | |
| Interaction | VDR interactions | 1.04e-04 | 127 | 74 | 5 | int:VDR | |
| Interaction | GCM1 interactions | 1.14e-04 | 68 | 74 | 4 | int:GCM1 | |
| Interaction | TDG interactions | 1.21e-04 | 69 | 74 | 4 | int:TDG | |
| Interaction | EGR1 interactions | 1.43e-04 | 72 | 74 | 4 | int:EGR1 | |
| Interaction | PLRG1 interactions | 1.43e-04 | 216 | 74 | 6 | int:PLRG1 | |
| Interaction | CWF19L1 interactions | 1.59e-04 | 74 | 74 | 4 | int:CWF19L1 | |
| Interaction | NUP35 interactions | 1.61e-04 | 424 | 74 | 8 | int:NUP35 | |
| Interaction | ETV1 interactions | 1.62e-04 | 29 | 74 | 3 | int:ETV1 | |
| Interaction | TGS1 interactions | 1.67e-04 | 75 | 74 | 4 | int:TGS1 | |
| Interaction | GPBP1 interactions | 1.67e-04 | 75 | 74 | 4 | int:GPBP1 | |
| Interaction | WDR5 interactions | KMT2C ADRM1 YBX1 MYO18A ZMYM2 E2F4 SNRPB LSM5 CREBBP EP300 MEIS2 TBP HELLS | 1.68e-04 | 1101 | 74 | 13 | int:WDR5 |
| Interaction | ERG interactions | 1.70e-04 | 223 | 74 | 6 | int:ERG | |
| Interaction | NCOA6 interactions | 1.94e-04 | 145 | 74 | 5 | int:NCOA6 | |
| Interaction | NCOA1 interactions | 2.01e-04 | 146 | 74 | 5 | int:NCOA1 | |
| Interaction | HNF1A interactions | 2.14e-04 | 80 | 74 | 4 | int:HNF1A | |
| Interaction | ANKRD35 interactions | 2.18e-04 | 32 | 74 | 3 | int:ANKRD35 | |
| Interaction | IRF1 interactions | 2.47e-04 | 83 | 74 | 4 | int:IRF1 | |
| Interaction | SP3 interactions | 2.59e-04 | 84 | 74 | 4 | int:SP3 | |
| Interaction | HOXA9 interactions | 2.62e-04 | 34 | 74 | 3 | int:HOXA9 | |
| Interaction | IRF4 interactions | 2.71e-04 | 85 | 74 | 4 | int:IRF4 | |
| Interaction | CTNNB1 interactions | ANKRD35 JUN RHOD EP400 YBX1 ZMIZ2 NFYA ZMIZ1 SAPCD1 CREBBP EP300 CDON | 2.89e-04 | 1009 | 74 | 12 | int:CTNNB1 |
| Interaction | GSC interactions | 2.96e-04 | 87 | 74 | 4 | int:GSC | |
| Interaction | STAT6 interactions | 2.96e-04 | 87 | 74 | 4 | int:STAT6 | |
| Interaction | E2F5 interactions | 3.11e-04 | 36 | 74 | 3 | int:E2F5 | |
| Interaction | HOXB2 interactions | 3.11e-04 | 36 | 74 | 3 | int:HOXB2 | |
| Interaction | MAPK14 interactions | 3.13e-04 | 353 | 74 | 7 | int:MAPK14 | |
| Interaction | SOX10 interactions | 3.67e-04 | 92 | 74 | 4 | int:SOX10 | |
| Interaction | FOXI1 interactions | 3.67e-04 | 92 | 74 | 4 | int:FOXI1 | |
| Interaction | PHOX2A interactions | 3.67e-04 | 8 | 74 | 2 | int:PHOX2A | |
| Interaction | PHAX interactions | 3.74e-04 | 167 | 74 | 5 | int:PHAX | |
| Interaction | NANOG interactions | 3.77e-04 | 481 | 74 | 8 | int:NANOG | |
| Interaction | SERTAD2 interactions | 3.95e-04 | 39 | 74 | 3 | int:SERTAD2 | |
| Interaction | LSM6 interactions | 3.98e-04 | 94 | 74 | 4 | int:LSM6 | |
| Interaction | NCOR2 interactions | 4.20e-04 | 264 | 74 | 6 | int:NCOR2 | |
| Interaction | TFF1 interactions | 4.58e-04 | 41 | 74 | 3 | int:TFF1 | |
| Interaction | TLX1 interactions | 4.63e-04 | 175 | 74 | 5 | int:TLX1 | |
| Interaction | ATF4 interactions | 4.66e-04 | 98 | 74 | 4 | int:ATF4 | |
| Interaction | SS18L1 interactions | 4.66e-04 | 98 | 74 | 4 | int:SS18L1 | |
| Interaction | HOXB3 interactions | 4.71e-04 | 9 | 74 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 4.71e-04 | 9 | 74 | 2 | int:ARGFX | |
| Interaction | TEAD1 interactions | 4.75e-04 | 176 | 74 | 5 | int:TEAD1 | |
| Interaction | NFYC interactions | 4.88e-04 | 177 | 74 | 5 | int:NFYC | |
| Interaction | BRF2 interactions | 4.92e-04 | 42 | 74 | 3 | int:BRF2 | |
| Interaction | NPAS2 interactions | 4.92e-04 | 42 | 74 | 3 | int:NPAS2 | |
| Interaction | JDP2 interactions | 4.92e-04 | 42 | 74 | 3 | int:JDP2 | |
| Interaction | PRKRIP1 interactions | 5.28e-04 | 43 | 74 | 3 | int:PRKRIP1 | |
| Interaction | RARB interactions | 6.44e-04 | 46 | 74 | 3 | int:RARB | |
| Interaction | HNF1B interactions | 6.72e-04 | 190 | 74 | 5 | int:HNF1B | |
| Interaction | KLF15 interactions | 6.88e-04 | 290 | 74 | 6 | int:KLF15 | |
| Interaction | EN1 interactions | 7.21e-04 | 110 | 74 | 4 | int:EN1 | |
| Interaction | PAX8 interactions | 7.46e-04 | 111 | 74 | 4 | int:PAX8 | |
| Interaction | FOSB interactions | 7.76e-04 | 49 | 74 | 3 | int:FOSB | |
| Interaction | AKAP7 interactions | 7.76e-04 | 49 | 74 | 3 | int:AKAP7 | |
| Interaction | TBR1 interactions | 7.97e-04 | 113 | 74 | 4 | int:TBR1 | |
| Interaction | TFAP2A interactions | 8.24e-04 | 114 | 74 | 4 | int:TFAP2A | |
| Interaction | GATA2 interactions | 8.28e-04 | 199 | 74 | 5 | int:GATA2 | |
| Interaction | E2F1 interactions | 8.47e-04 | 200 | 74 | 5 | int:E2F1 | |
| Cytoband | 10q22.3 | 5.33e-05 | 43 | 77 | 3 | 10q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 4.28e-04 | 208 | 77 | 4 | chr10q22 | |
| GeneFamily | Zinc fingers MIZ-type | 5.01e-07 | 7 | 45 | 3 | 85 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.56e-06 | 17 | 45 | 3 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.04e-04 | 18 | 45 | 2 | 91 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.75e-03 | 25 | 45 | 2 | 775 | |
| GeneFamily | Collagens | 5.85e-03 | 46 | 45 | 2 | 490 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.63e-05 | 259 | 75 | 7 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.55e-05 | 277 | 75 | 7 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.19e-05 | 406 | 75 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NCOA3 KMT2C COL16A1 TENM4 ZNF618 ZMIZ1 GRM7 CREBBP MEIS2 CDON HELLS | 9.84e-05 | 790 | 75 | 11 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.03e-04 | 413 | 75 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NCOA3 KMT2C COL16A1 TENM4 ZNF618 ZMIZ1 GRM7 CREBBP MEIS2 CDON HELLS | 1.11e-04 | 801 | 75 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| Disease | Menke-Hennekam syndrome | 6.37e-06 | 2 | 75 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 6.37e-06 | 2 | 75 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 6.37e-06 | 2 | 75 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.37e-06 | 2 | 75 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.37e-06 | 2 | 75 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 6.37e-06 | 2 | 75 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 6.37e-06 | 2 | 75 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 6.37e-06 | 2 | 75 | 2 | C0035934 | |
| Disease | Endometrial Stromal Sarcoma | 6.34e-05 | 5 | 75 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 9.50e-05 | 6 | 75 | 2 | C0334488 | |
| Disease | Carcinoma, Transitional Cell | 1.57e-04 | 41 | 75 | 3 | C0007138 | |
| Disease | tauopathy (implicated_via_orthology) | 2.83e-04 | 10 | 75 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | cancer antigen 125 measurement | 2.83e-04 | 10 | 75 | 2 | EFO_0010603 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 6.55e-04 | 15 | 75 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | 2-hydroxyglutarate measurement | 7.48e-04 | 16 | 75 | 2 | EFO_0021506 | |
| Disease | cigarettes per day measurement | 8.78e-04 | 438 | 75 | 6 | EFO_0006525 | |
| Disease | Leukemia, Myelocytic, Acute | 1.00e-03 | 173 | 75 | 4 | C0023467 | |
| Disease | colorectal adenoma (is_marker_for) | 1.18e-03 | 20 | 75 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_marker_for) | 1.34e-03 | 85 | 75 | 3 | DOID:3910 (is_marker_for) | |
| Disease | chronic widespread pain | 1.56e-03 | 23 | 75 | 2 | EFO_0010099 | |
| Disease | Schizophrenia | 1.79e-03 | 883 | 75 | 8 | C0036341 | |
| Disease | Squamous cell carcinoma of esophagus | 1.85e-03 | 95 | 75 | 3 | C0279626 | |
| Disease | Adenoid Cystic Carcinoma | 2.14e-03 | 100 | 75 | 3 | C0010606 | |
| Disease | Sezary Syndrome | 2.15e-03 | 27 | 75 | 2 | C0036920 | |
| Disease | Tonic Seizures | 2.26e-03 | 102 | 75 | 3 | C0270844 | |
| Disease | Absence Seizures | 2.26e-03 | 102 | 75 | 3 | C4316903 | |
| Disease | Myoclonic Seizures | 2.39e-03 | 104 | 75 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.39e-03 | 104 | 75 | 3 | C0494475 | |
| Disease | facial width measurement | 2.45e-03 | 105 | 75 | 3 | EFO_0007855 | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 2.48e-03 | 29 | 75 | 2 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | glutamate measurement | 2.48e-03 | 29 | 75 | 2 | EFO_0010487 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQPGLVTPVAQGMGS | 311 | Q09472 | |
| ASPMGVNGGVGVQTP | 511 | Q09472 | |
| APGPVVMQTVSQAGA | 1671 | Q96L91 | |
| GAAQFAAAMGVPEIP | 121 | Q7L266 | |
| QGTVTDMAGRPGQPG | 731 | Q07092 | |
| SQAGGQPMGATGVNP | 281 | Q92793 | |
| GGTVAEPVGPAAMNQ | 476 | Q8N283 | |
| SGPGVVVMQLNVPNG | 701 | Q9Y2K5 | |
| QGVLVQPGVDQPGMV | 491 | Q9H0J4 | |
| GPASPQADGQNMVEP | 261 | A6NDH6 | |
| GAAAFGELQNQMPGP | 466 | Q92932 | |
| GNIATAPGFMIGQTP | 16 | Q9C0D6 | |
| MDRGAAAAQGTAPPQ | 1 | Q5KSL6 | |
| PAGSGGSEAPAMVEQ | 6 | Q9NRZ9 | |
| VEPVGPSTPNMAAGQ | 3661 | Q8NEZ4 | |
| TSAAQPVNGAGMVAP | 131 | P05412 | |
| PVNGAGMVAPAVASV | 136 | P05412 | |
| PEGQPMGSFVLDGQQ | 361 | O14770 | |
| QAGKLAPANGMPTGE | 631 | O95202 | |
| PANGSGLPQFVVQMG | 1216 | Q9ULL4 | |
| MIVDTPGFQNPEQGG | 786 | Q92614 | |
| GVGPASVMVGNLVAG | 951 | Q9P265 | |
| QIFGQGGEMPGEAAV | 86 | P54098 | |
| QGDPAFPEMNGNGAV | 61 | Q96MY1 | |
| MGLGVSAEQPAGGAE | 1 | Q9BQQ3 | |
| GNNITMLVPGGEGPE | 76 | Q9Y4Y9 | |
| VDGSPGMLEQAQAPG | 96 | Q8N6F8 | |
| GNFGNIPAPMTVGNI | 1201 | O94913 | |
| MTAAQAAGEEAPPGV | 1 | O00212 | |
| NPAPANMEGGGGSVA | 26 | Q9UP83 | |
| LFGGQAEGPPVTNIM | 41 | Q9H3Q3 | |
| AVPGSAEVQGMAGPA | 251 | Q16254 | |
| VNGGGMYTAVPQIDP | 1091 | Q4KMG0 | |
| MGNAAGSAEQPAGPA | 1 | O95466 | |
| ALGGMGPDTAPQAQV | 131 | Q8IXV7 | |
| AGTPVMFNKNGDAPG | 461 | Q14831 | |
| DGEMAEAPGSPRQQG | 156 | Q66K89 | |
| GNTGMVGGSVPVFDE | 131 | Q8N465 | |
| PIMVQAVPGGQGQTI | 76 | P23511 | |
| AVPGGQGQTIMQVPV | 81 | P23511 | |
| AAPVVPVMAAQVVGG | 251 | Q8IVF1 | |
| AAPVVPVMAAQVVGG | 251 | A6NNL0 | |
| AAPVVPVMAAQVVGG | 251 | B1AL46 | |
| VRGVGGPSQQVMTPQ | 131 | P63162 | |
| AMAPRTGPAQGGQVA | 436 | O75157 | |
| GMGQQPDPAFGRVSS | 1316 | Q9Y6Q9 | |
| VRGVGGPSQQVMTPQ | 131 | P14678 | |
| GPGVLSMANAGPNTN | 136 | P30405 | |
| TGLGMPPQNVGEVYG | 281 | P30520 | |
| MGSQGSGGVPLVQAP | 1 | Q5SSQ6 | |
| ASIVHAEPPGGMQQG | 16 | P20265 | |
| GQPGAMADQSAGQPS | 661 | Q17R89 | |
| PPQEGMVPVAQAGSS | 541 | Q14162 | |
| PGVMDGVPSANNYQG | 261 | P31937 | |
| LATMNVPAGPAGGQQ | 271 | Q16186 | |
| PGQAVMPEGFIKAGQ | 516 | Q03692 | |
| DACPVGFTGPMVQGV | 351 | P35443 | |
| MNQPGGAAAPQADGA | 1 | Q5T7W0 | |
| PPVQGEVMEGADNQG | 211 | P67809 | |
| AQGLASPQGAMTPGI | 11 | P20226 | |
| TPGLNGQMPAAQEGA | 221 | O15533 | |
| GVDPGAPGMQVTTDG | 46 | P29144 | |
| ATPVGNRESPGQAGM | 316 | Q9BUG6 | |
| DGQTVAGEVMGPQRP | 326 | Q5JSH3 | |
| VSQQPPVIGSIMGNG | 1196 | Q6N022 | |
| DPAGMGGTYQQPANT | 206 | O43759 | |
| AAPGLIGNVMGQSPS | 351 | Q8IYB5 | |
| MGPAVLGQGQEGQPE | 1 | H0YL09 | |
| GPVGSMENGKPGADV | 451 | Q8N2W9 | |
| ATQSQVLGNPMGPAG | 51 | Q8NF64 | |
| VGPFNPGRMNVAGDV | 256 | Q9UBW7 | |
| GPNAGEVTQGFAAAM | 586 | Q86VQ6 | |
| MAVQTPVPTAAGGSG | 776 | Q6ZS17 | |
| MADTTPNGPQGAGAV | 1 | P57088 | |
| MAAPAQQTTQPGGGK | 1 | Q9NXG2 | |
| GMNAAINTGPAPAVT | 76 | Q6PEX7 | |
| GQAGAQGASDMPEPS | 1016 | Q9ULJ6 | |
| PGAPASQMVQVVPAG | 1016 | Q5EBL2 | |
| SQMVQVVPAGAGPGV | 1021 | Q5EBL2 | |
| FLPAMIGGQEGQASP | 921 | Q6PIF6 | |
| PDMVGGNAVPQRTAG | 551 | Q6NSJ0 | |
| LGPGQGEQGMTVAVV | 21 | Q14957 |